NEW YORK (GenomeWeb) – What were the articles that gained the most interest from GenomeWeb readers last week? Here are the top five:
1) Class Action Lawsuits Filed Against Cancer Genetics
2) Clinically Validated NGS Assays Miss Challenging But Important Variants, Study Finds
3) Illumina, Loxo Oncology to Develop Pan-Cancer Companion Diagnostic
4) Commercial Payors Unlikely to Follow CMS Policy on NGS Cancer Panels in Short Term, Survey Suggests
5) FDA Finalizes NGS Guidances; Proposes Guidance on Investigational IVDs in Cancer Rx Trials